Interferon-γ Inhibits Ebola Virus Infection

Area of Science:

• Virology
• Immunology
• Drug Discovery

Background:

• Ebola virus outbreaks are a significant global health threat with no currently available antiviral treatments.
• Filoviruses, including Ebola virus, cause severe and often fatal hemorrhagic fevers.
• Macrophages are identified as early cellular targets for Ebola virus infection.

Purpose of the Study:

• To investigate the potential of interferon gamma as a prophylactic or therapeutic agent against Ebola virus infection.
• To determine the mechanism by which interferon gamma inhibits Ebola virus replication.
• To identify novel antiviral targets by examining interferon-stimulated genes.

Main Methods:

• Administration of murine interferon gamma to mice challenged with mouse-adapted Ebola virus.
• In vitro studies assessing the effect of interferon gamma on Ebola virus-infected macrophages.
• Analysis of viral RNA levels and protein synthesis inhibition.
• Microarray analysis of interferon gamma-treated human macrophages to identify interferon-stimulated genes.

Main Results:

• Interferon gamma administration 24 hours before or after infection robustly protected mice from lethal Ebola virus challenge.
• Treatment with interferon gamma significantly reduced morbidity and serum viral titers in infected mice.
• Interferon gamma profoundly inhibited Ebola virus infection in macrophages, reducing viral RNA levels.
• Studies suggest interferon gamma blocks virus replication, a process requiring protein synthesis.
• Over 160 interferon-stimulated genes were identified, with some showing inhibitory effects on Ebola virus infection.

Conclusions:

• Interferon gamma demonstrates significant prophylactic and therapeutic potential against Ebola virus infection.
• The drug's mechanism involves inhibiting virus replication in macrophages, a key early target.
• Identified interferon-stimulated genes offer new avenues for targeting negative-strand RNA viruses like Ebola.
• Interferon gamma, being an FDA-approved drug, could be rapidly deployed for future filovirus outbreaks.